Researchers
GOPALAKRISHNAPILLAI, ANILKUMAR PHD, MOTH (MTECH), MS
Nemours Children's Hospital, Delaware
INCLUDE Grants
DLK1 as a novel target for Down syndrome myeloid leukemia
Grant Number
R01CA282730
NIH Institute
NCI
Mechanism
R01
PROJECT NARRATIVE
PUBLIC HEALTH RELEVANCE
Chemotherapy-related toxicity and disease relapse with poor prognosis are the major impediments for
a complete cure for Down syndrome associated myeloid leukemia (DS-ML). In this project, we propose
different approaches to combat DS-ML. These approaches will provide a preclinically validated toolbox
consisting of novel therapeutic options and combinations, not only for TAM/DS-ML, but also for other myeloid
malignancies.